Cipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...

Cipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...

Scientists couldn’t crack the science because enzymes in the stomach break down and digest the proteins, which are therefore not absorbed i...

French co plans to bring raft of innovative products, including preventive dengue vaccine; move may improve company’s prospects over its ri...